Quang X Pham insider trades

Open-market stock purchases and sales by Quang X Pham, Chairman and CEO at Cadrenal Therapeutics, Inc, from SEC Form 4 filings since Feb 10, 2023.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +9%.

Recent trades

DateStockTradeValue
Oct 9, 2026CVKD Cadrenal Therapeutics, IncBought (not open market)—
Jun 29, 2026CVKD Cadrenal Therapeutics, IncSold$22.4K
Jun 26, 2026CVKD Cadrenal Therapeutics, IncSold$27.5K
Jun 25, 2026CVKD Cadrenal Therapeutics, IncSold$6.4K
Jun 23, 2026CVKD Cadrenal Therapeutics, IncSold$7.3K
Jun 22, 2026CVKD Cadrenal Therapeutics, IncSold$32.5K
Jun 17, 2026CVKD Cadrenal Therapeutics, IncSold$1.6K
Jun 16, 2026CVKD Cadrenal Therapeutics, IncSold$11.5K
Jun 15, 2026CVKD Cadrenal Therapeutics, IncSold$13.1K
Jun 12, 2026CVKD Cadrenal Therapeutics, IncSold$51.2K
Jun 11, 2026CVKD Cadrenal Therapeutics, IncSold$6K
Jun 10, 2026CVKD Cadrenal Therapeutics, IncSold$14.7K
Jun 9, 2026CVKD Cadrenal Therapeutics, IncSold$52.7K
Jun 8, 2026CVKD Cadrenal Therapeutics, IncSold$25.8K
Jun 5, 2026CVKD Cadrenal Therapeutics, IncSold$9.1K
Jun 4, 2026CVKD Cadrenal Therapeutics, IncSold$17.2K
Jun 3, 2026CVKD Cadrenal Therapeutics, IncSold$9.9K
Jun 2, 2026CVKD Cadrenal Therapeutics, IncSold$1.6K
May 29, 2026CVKD Cadrenal Therapeutics, IncSold$1.5K
May 28, 2026CVKD Cadrenal Therapeutics, IncSold$14.7K
May 22, 2026CVKD Cadrenal Therapeutics, IncSold$6.6K
May 12, 2026CVKD Cadrenal Therapeutics, IncSold$17.4K
May 11, 2026CVKD Cadrenal Therapeutics, IncSold$37.3K
Oct 27, 2025CVKD Cadrenal Therapeutics, IncSold$18.4K
Oct 24, 2025CVKD Cadrenal Therapeutics, IncSold$15.8K

Companies traded

  • CVKD Cadrenal Therapeutics, Inc: 3 buys, 33 sales, last Oct 9, 2026

Get free alerts when Quang X Pham files a new trade →